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Abstract
Objectives: To determine if the Patient-Reported Outcome Measurement Information System (PROMIS) physical function, pain interference,
self-efficacy, and global rating of normal function (GRNF) scales are able to accurately characterize a patient’s acceptable symptom state (PASS).
Design: A cross-sectional analysis, using receiver operator curves and chi-square analysis to explore criteria to determine thresholds (80% and
95% sensitivity/specificity) for PASS that are applicable to PROMIS and GRNF scales.
Setting: Phone survey after primary care.
Participants: Patients (NZ94) attending primary care for musculoskeletal problems.
Interventions: Not applicable.
Main Outcomes Measures: Accuracy and proportion of patients classified as PASS Yes or No.
Results: Receiver operator curve analysis showed significant area under the curve (AUC) values for each PROMIS scale (AUC>.72) and the
GRNF rating (AUCZ.74). Identified PROMIS thresholds suggested PASS was achieved when scores were at or slightly worse than the US
population average. A score of 7 and 4 characterized patients that were PASS Yes and No, respectively, on the GRNF rating. A moderate
(80%) specificity/sensitivity criteria yielded 72.3%-73.5% accuracy for a majority of participants (>69.9%).
Conclusion: This analysis suggests the PROMIS and GRNF scales are able to characterize PASS status with moderate accuracy (w70%) for a
large portion of patients (w70%). New to this study is the association of self-efficacy with PASS status. PROMIS scales at or slightly worse than
the US population average characterized PASS status.
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There is enthusiasm for new generic patient-reported outcomes
(PRO), such as the Patient-Reported Outcome Measurement
Information System (PROMIS), to assess patient status of
musculoskeletal problems in primary care.1-5 The generic
PROMIS scales are not disease specific, making them applicable
across diagnoses.1-5 Also, use of computer adaptive testing (CAT)
reduces floor and ceiling effects while maintaining low patient
burden (ie, average completion time is <1min per scale).5-7
However, selection of specific domains of health for targeted
groups of patients and the interpretation of PROMIS scales are
still evolving.
Ideally, health domains for PRO assessment should match the
patient’s needs and inform provider decisions. The PROMIS
physical function (PF) and pain interference (PI) scales have
demonstrated validity for tracking patients with musculoskeletal
problems.4,5,8,9 Self-efficacy (SE), the concept of the ability to act
on one’s own behalf, is a positive behavioral health attribute
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associated with health outcomes.10 Because individuals ultimately
will self-manage their musculoskeletal problems,11 understanding
a patients’ confidence in managing their symptoms may influence
provider decisions of how much and what kind of support is
needed. The PROMIS SE of symptom management scale may
serve this purpose, complementing the PROMIS PF and PI scales
in a primary care setting.
Another PRO that is potentially useful in primary care is
associated with the patient’s internal reference of whether their
joint or body region is healthy. Global ratings of normal function
(GRNF) are included in current scales to capture a patient’s rating
of their joint relative to healthy joints.12-14 The GRNF scale
contrasts with the PROMIS scales by asking the patient to judge
whether their joint or body region is normative rather than
measuring a specific health domain. Previous data document that
differences on how a question is framed, relative to function, can
lead to distinct differences in patient responses.15 Patients may
place more importance on a sense of normative functioning of a
joint rather than their abilities relative to a specific health domain
(ie, PF, PI, SE).
Key challenges to using the new PROMIS and GRNF scales
are knowing which scale to use and how to best apply them to
patient decisions.15,16 Patient acceptable symptom state (PASS) is
a single yes or no question that asks patients to judge whether they
are satisfied with their current level of symptoms and activity.17-22
This validated question is useful to establish what score might be
important for patients to achieve on the PROMIS and GRNF
scales to be satisfied with their care.23 Previous studies of disease-
specific scales suggest a PASS level is associated with normative
values or slightly worse.19,22 Similar PASS thresholds are not
known for PROMIS or GRNF. PROMIS PF and PI are expected to
predict PASS status because their constructs are consistent with
measuring activity and symptoms. It is unclear whether PROMIS
scales unrelated to symptoms or activity, such as PROMIS SE,
will also predict a patient’s PASS state.18,19 The ability of
PROMIS SE to predict PASS status would support its application
to patient care. Identifying the threshold for PASS Yes and No on
the PROMIS and GRNF scales would help providers applying
these scales to practice understand when patients reach an
acceptably low symptom and high activity state or when symp-
toms and activity are unacceptably high and low,
respectively.18,19,21,22
The first purpose of this study was to determine if selected PRO
scales (PROMISPF, PI, SE, andGRNF) scales are able to accurately
classify an individual’s PASS status shortly (<45 days) after
collaborative physical therapist (PT) and medical doctor (MD)
primary care service. The short-term follow-up (<45 days) was
emphasized because this corresponds to when patients may decide
to seek further care if recovery is slow. The second purpose was to
improve interpretation of each scale by evaluating 2 thresholds
providers may use to determine PASS status. Although a single
threshold per scale is optimal, it was anticipated that participants at
the midrange of the scales would not classify accurately.8,10,24
Therefore, 2 criteria based on high (95%) and moderate (80%)
sensitivity/specificity were compared to determine if focusing on
scores that were either higher or lower than the midrange might
accurately classify participants. The hypothesis was that high
sensitivity/specificity (95%) would result in higher accuracy for a
lower proportion of participants. A priori it was unclear if a
moderate sensitivity or specificity (80%) might achieve adequate
accuracy while identifying a higher proportion of participants.
Methods
Overview
This cross-sectional study surveyed patients by phone after their
primary care visit for a musculoskeletal problem. The survey
included PASS, GRNF, and PROMIS outcome scales. The anal-
ysis focuses on the accuracy and proportion of patients classified
for PASS using the GRNF and PROMIS scales.
Participants
Patients who attended a rural primary care service from October
2016 to December 2016 were surveyed 7-42 days (average,
13.87.3 days) after their primary care encounter (table 1). As
part of their initial intake patients agreed to receive a call back to
assess the service they received. This agreement included a signed
consent that complied with a protocol approved by George Fox
University. The goal was to call patients within 30 days of their
clinic visit. There were no other inclusion and/or exclusion
criteria applied.
The collaborative PT and MD primary care service consisted of
evaluation and treatment during the primary care MD visit. The
PT service included consultation for (1) diagnosis, (2) need for
imaging, and/or (3) referral to another provider. In addition, nearly
all patients received minimal treatment including manual therapy
(w30%), exercise (>90%), and education (>90%). Time with
patients varied from a few minutes to 45 minutes depending on
clinical presentation and the patient’s needs.
Measures
The CAT PROMIS PF, PI, and SE scales were used to assess
patients at follow-up. All CAT PROMIS scales were scored using
the web-based assessment center (https://assessmentcenter.net/)
website. The CAT PROMIS PF version 1.2 asks patients to rate
their level of difficulty performing functional activities. The CAT
approach selects appropriately difficult activities, avoiding floor
and ceiling effects, in less time than traditional tests.3,6,24 Simi-
larly, the CAT PROMIS PI scale asks patients to rate the degree to
which pain interferes with aspects of their life. For both scales a T
score of 50 is the average of the US population, and 10 points
represents 1 SD. For PROMIS PF higher scores indicate improved
PF and for the PI scale lower scores indicate less PI. The CAT
PROMIS SE asks patients to rate their confidence in their ability
to manage symptoms. This PROMIS SE scale demonstrated
concurrent validity with established scales in patients with a
variety of medical conditions.10 Although the CAT PROMIS SE
also determines a T score (higher scores indicate higher SE), the
List of abbreviations:
AUC area under the curve
GRNF global rating of normal function
PASS patient acceptable symptom state
PF physical function
PI pain interference
PROMIS Patient-Reported Outcome Information
System
SE self-efficacy
reference population consists of patients managing a spectrum of
chronic health issues.10 A T score of 50 represents the average of
people managing chronic health conditions, and 10 points is 1 SD.
A GRNF rating asks patients to rate their joint and/or body region
relative to healthy joints and/or body regions. A global rating is
used widely in psychology to capture a broad judgement from the
patient regarding various attributes.14 Similarly, they are used in
rehabilitation scales to capture healthy function.12,25 In this study,
participants were asked to rate their joint (eg, knee) or body region
(eg, lower back) relative to healthy function. The caller altered the
joint or body region (table 2) for the primary or treated problem
determined from the medical record. For patients with multiple
problems (24%) the patient answered relative to their pri-
mary problem.
“How would you rate the function of your
_________________ [Fill in joint problem] on a scale of 0 to 10
with 10 being normal, excellent function, and 0 being the inability
to perform any of your usual daily activities, which may
include sports?”
The PASS question was derived from previous studies that
sought to define when patients reached a point of symptoms and
activity that they judged satisfactory.17 A common wording to
define a PASS state was, “Taking into account all the activities you
do during your daily life, your level of pain, and also your func-
tion, do you consider your current state satisfactory?”17 A PASS
Yes state is consistent with low levels of pain and moderate levels
of function on other PRO scales that approximate normative
values or slightly worse than normative in patients with muscu-
loskeletal problems.19,22
Data analysis
For the first purpose, receiver operator curves were used to
determine accuracy (ie, area under the curve [AUC]) for each PRO
scale to predict PASS. An AUC >0.7 is considered reasonably
accurate and, therefore, was adopted as a minimum.26 For sample
size, a prevalence of 30% PASS Yes responses was used. A sample
of 90 participants at a 95% CI enables the detection of an AUC as
low as .57. To evaluate if a single threshold was useful, the
shortest distance to no errors (sensitivity/specificityZ1) on the
receiver operator curve was assessed. A clear minimum indicates
an optimal threshold that balances errors (ie, relatively equal false
positives and/or negatives). When there is no clear minimum (ie,
flat region) (fig 1), this indicates consistent errors over this range
of the scale. No clear minimum suggests there is no optimal single
threshold, but rather that using high and low thresholds (ie, outside
the flat region) may demonstrate the potential of the scale for a
proportion of participants outside the region where errors are
higher (ie, flat region). Because the midrange of the PROMIS
Table 2 The mean  SD for each PROMIS health domain by body
region
Body Region
(Percentage of Sample) PE PF SE
Spine (back/neck) (35.3%) 57.67.7 43.17.8 45.86.5
Shoulder (14.1%) 57.76.3 42.111.3 44.65.9
Knee (14.1%) 57.77.0 42.39.2 47.78.9
Hip (10.6%) 53.98.1 49.415.2 49.89.9
Other (1.1%)* 64.2 45.7 42.4
>1 body region (24.7%) 58.35.6 43.58.1 48.26.9
* For this category nZ1 patient, so no SDs are given.
Fig 1 The ratio of false positives (1-specificity) (gray filled circles)
and false negatives (1-sensitivity) (black open circles) for deter-
mining a participant’s PASS from their PROMIS PI scale is shown. The
shortest distance to no errors (black hashed) is flat at a ratio of 0.45.
The 80% and 95% sensitivity/specificity criteria for determining
thresholds for PASS are shown. The region that shows poor ability to
discriminate a participant’s PASS state is illustrated by the flat region
with no clear minima.
Table 1 Comparison of demographic and patient-reported outcomes between PASS Yes and PASS No participants
PASS No (nZ49) PASS Yes (nZ45) P Value
Demographic Variables
Age (y) 61.7 (15.8) 65.4 (15.3) .25*
Sex (% female) 67.3 66.7 .56y
Height (cm) 168.1 (10.2) 167.2 (9.2) .74*
Weight (kg) 84.9 (25.4) 86.4 (19.3) .68*
Body mass index (kg/cm2) 30.9 (8.2) 31.8 (6.7) .55*
PROMIS PI 60.1 (6.1) 54.8 (7.1) <.01z
PROMIS PF 39.6 (6.5) 47.0 (10.5) <.01z
PROMIS SE: Symptom Management 43.6 (4.5) 50.0 (10.5) <.01z
GRNF (nZ93) 4.9 (1.8) 6.8 (2.0) <.001*
* Independent t test.
y Chi-square test of proportions.
z Pairwise comparison (2-way analysis of variance).
scales corresponded to a flat region, thresholds closest to 80%/
95% sensitivity/specificity were identified and used to classify
participants. Participants that showed better scores than the 80%/
95% specificity thresholds were classified as PASS Yes. Partici-
pants that showed worse scores than the 80%/95% sensitivity
thresholds were classified as PASS No. Participants between the
80%/95% sensitivity/specificity thresholds were identified as
unclassified.
To assess the clinical use of the thresholds (95%/80% sensi-
tivity/specificity) the accuracy and proportion of patients classified
were evaluated using chi-square analysis. For each PRO scale 32
tables were assessed for each classification. The rows of each 32
table were patients classified by PRO as PASS Yes, PASS No, and
PASS unclassified, and the columns were the participants PASS
Yes and No responses. This resulted in 8 32 tables, 1 for each
PRO scale using the 2 different thresholds. The accuracy and
proportions of patients classified were used to understand clinical
impact of using the reported PASS thresholds in practice. An alpha
level of .05 and SPSS v23 was used for all analyses.
Logistic regression was used to assess the potential for age,
sex, body mass index (BMI), and length of follow-up to confound
the prediction of PASS status. For each classification of PASS
(nZ8) PRO variables were converted to a nominal variable using
the derived thresholds (PASS YesZ1, 0 and PASS NoZ1, 0).
Logistic regression models for each PRO were then completed
(nZ16) with the nominal variable PRO score, age, sex, BMI, and
length of follow-up entered in each model. If the PRO nominal
variable was significant, this suggested the PRO is an independent
predictor of PASS.
Results
There were approximately equal numbers of PASS Yes (nZ45)
and PASS No (nZ49) participants (see table 1). The spectrum of
musculoskeletal problems included most body regions (see
table 2). A total of 169 patients were called; 112 were reached by
phone, and 94 completed surveys. One patient did not complete
the GRNF rating. Only 18 patients declined to participate when
reached, yielding an 83.9% (94/112) participation rate, accounting
for 55.6% (94/169) of all calls attempted. The total participation
of all patients seen during this time period was 22.2% (94/405).
The AUC for all of the PROMIS scales and GRNF were sta-
tistically significant and higher than 0.7 (table 3). The highest
AUC was for PROMIS SE (.76; P<.01), and the lowest AUC was
for PROMIS PF (.72; P<.01). The closest thresholds to 95%
specificity/sensitivity (PASS Yes/PASS No, respectively) were
51.4/63.2 for PROMIS PI, 50.6/33.7 for PROMIS PF, and
50.80/41.0 for PROMIS SE (table 4). The closest thresholds to
80% specificity/sensitivity (PASS Yes/PASS No, respectively)
were 56.2/60.4 for PROMIS PI, 45.4/39.8 for PROMIS PF,
and 47.6/43.4 for PROMIS SE (see table 4). The closest
threshold to 95% specificity/sensitivity (PASS Yes/PASS No,
respectively) below 100% for GRNF was 8/3. The closest
threshold to 80% specificity/sensitivity (PASS Yes/PASS No,
respectively) for GRNF was 7/4.
The 8 chi-square analyses for all PROs were significant
(table 5 and 6). The combined accuracy for classifying partici-
pants as PASS Yes or No using the 95% specificity/sensitivity
criteria ranged from 75%-79.4%. The proportion of participants
classified as PASS Yes or No ranged from 25.6%-42.0% (see
table 5). The combined accuracy for classifying participants as
PASS Yes or No using the 80% specificity/sensitivity criteria
ranged from 72.3% to 73.5% (see table 6). The proportion of
participants classified as PASS Yes or No ranged from 69.9%
to 75.5%.
Logistic regression analysis showed that all PROs evaluated
remained significant (P<.05) predictors of PASS irrespective of
possible confounding factors included in the model.
Discussion
The key findings are that the PROMIS and GRNF scales are able
to characterize PASS status with moderate accuracy (w70%) for a
large portion of patients (w70%). Also, PROMIS SE, which is not
associated with physical abilities or symptoms and GRNF (which
references normative function), predicts PASS status as well as
PROMIS PF and PI (see table 3). The thresholds identified char-
acterize PASS Yes status as at or slightly worse than the US
population. However, the accuracy and proportion of patients
successfully classified into a PASS category may influence how
these scales are used. The 80% specificity/sensitivity criteria
identified thresholds that achieved 72.3%-73.5% accuracy for
Table 3 Results of receiver operator curve analysis
Area Under the Curve P Value
Scale/Question
PROMIS PI .73 (.63-.83) <.001




GRNF (nZ93) .74 (.64-.84) <.001
Table 4 Thresholds established using the 95% specificity/sensitivity and 80% specificity/sensitivity
Higher Thresholds (95%) Moderate Thresholds (80%)
Specificity /




Sensitivity (%) PASS No Not Classified PASS Yes
Scale/Question
PROMIS PI 93.3/93.9 63.2 51.5-63.1 51.4 80.0/79.6 60.4 56.3-60.3 56.2
PROMIS PF 93.3/93.9 33.7 33.8-50.5 50.6 79.6/80.0 39.8 39.9-45.3 45.4
PROMIS SE:
Symptom Management
89/93.9 40.9 41.0-50.8 50.9 79.6/82.2 43.4 43.5-47.5 47.6
GRNF (nZ93) 88/95.5 3 4-7 8 79.6/81.8 4 5-6 7
69.9%-75.0% of participants. There was little advantage to
applying the higher 95% specificity/sensitivity threshold criteria.
Clinically, this is encouraging for the use of patient-derived data
(ie, PROMIS scales) to be used to track outcomes; however, how
to identify all patients’ PASS status accurately was unresolved in
this study.
Table 5 Proportions of patients classified at a PASS Yes and PASS No by threshold derived from the nearest values 95%
specificity/sensitivity
PROMIS PASS Yes, No. (%) PASS No, No. (%) Total, No. (%) Accuracy (%) P Value*
PI
PASS No 65.0 3 (3.2) 6 (6.4) 9 (9.6) 66.7 ND
Unclassified 51.5-64.9 30 (31.9) 40 (42.6) 70 (74.5) NA ND
PASS Yes 51.4 12 (12.8) 3 (3.2) 15 (16.0) 80.0 .02
Total 45 (47.9) 49 (52.1) 94 (100.0) NA ND
PF
PASS No 33.8 3 (3.2) 8 (8.5) 11 (11.7) 72.3 ND
Unclassified 33.9-50.4 26 (27.7) 38 (40.4) 64 (68.1) NA ND
PASS Yes 50.5 16 (17.0) 3 (3.2) 21 (20.2) 76.2 <.01
Total 45 (47.9) 49 (52.1) 94 (100.0) NA ND
SE
PASS No 41.0 5 (5.3) 14 (14.9) 19 (20.2) 73.6 ND
Unclassified 41.1-51.0 24 (25.6) 32 (34.0) 46 (59.6) NA ND
PASS Yes 51.1 16 (17) 3 (3.2) 19 (20.2) 84.2 <.01
Total 45 (47.9) 49 (52.1) 94 (100.0) NA ND
Other
GRNF (nZ93)
PASS No 3 2 (2.2) 11 (11.8) 13 (14.0) 84.6 ND
Unclassified 4-7 22 (23.7) 32 (34.4) 54 (58.1) NA ND
PASS Yes 7 20 (21.5) 6 (6.5) 26 (28.0) 76.9 <.01
Total 44 (47.3) 49 (52.7) 93 (100.0) NA ND
Abbreviations: NA, not applicable; ND, no data.
* P value from chi-square analysis.
Table 6 Proportions of patients classified at a PASS Yes and PASS No by threshold derived from the nearest values 80%
specificity/sensitivity
PROMIS PASS Yes, No. (%) PASS No, No. (%) Total, No. (%) Accuracy (%) P Value*
PI
PASS No 60.4 9 (9.6) 25 (26.6) 34 (36.2) 73.5 ND
Unclassified 56.3-60.3 10 (10.6) 14 (14.9) 24 (25.5) NA ND
PASS Yes 56.2 26 (27.7) 10 (10.6) 36 (38.3) 72.2 <.01
Total 45 (47.9) 49 (52.1) 94 (100.0) NA ND
PF
PASS No 39.8 9 (9.6) 29 (30.9) 38 (40.4) 76.3 ND
Unclassified 39.9-45.3 13 (13.8) 10 (10.6) 23 (24.5) NA ND
PASS Yes 45.4 23 (24.5) 10 (10.6) 33 (35.1) 69.7 <.01
Total 45 (47.9) 49 (52.1) 94 (100.0) NA ND
SE
PASS No 43.4 8 (8.5) 25 (26.6) 33 (35.1) 75.8 ND
Unclassified 43.5-47.5 12 (12.8) 14 (14.9) 26 (27.7) NA ND
PASS Yes 47.6 25 (26.6) 10 (10.6) 35 (37.2) 71.4 <.01
Total 45 (47.9) 49 (52.1) 94 (100.0) NA ND
Other
GRNF (nZ93)
PASS No 4 8 (8.6) 20 (21.5) 28 (30.1) 71.4 ND
Unclassified 5-6 9 (9.7) 19 (20.4) 28 (30.1) NA ND
PASS Yes 7 27 (21.5) 10 (6.5) 37 (39.8) 72.9 <.01
Total 44 (47.3) 49 (52.7) 93 (100.0) NA ND
Abbreviations: NA, not applicable; ND, no data.
* P value from chi-square analysis.
A challenge with documenting outcomes in primary care is the
variety of diagnoses (see table 2). Despite a wide range of
diagnoses, the sample was nearly evenly split between PASS Yes
and No participants (see table 1). On average, patients that were
PASS No (see table 1) were experiencing low PF (39.6) and high
PI (60.1). PROMIS SE was also low (43.6), suggesting patients
had low confidence in their ability to manage their symptoms.
Overall, patients rated themselves as less than 5 out of 10 on the
GRNF. In contrast, average PROMIS scores were near 50 for
PASS Yes (within 5 points of 50), and GRNF was 7 out of 10. This
suggests that on average a PASS Yes score is near the US popu-
lation average (PROMIS scales) or 70% of normal (GRNF).
Consistent with previous studies, characterization of PASS Yes
was near the average of the US population or slightly worse (see
table 4).19,22 PASS Yes status (95% specificity/sensitivity) was
characterized by PI, PF, and SE scores within 1.4 points of a
T score of 50. The moderate criteria (80% specificity/sensitivity)
identified worse scores on the PROMIS scales by up to 5.1 points
and 1 point on the GRNF scale. This suggests patients judge
themselves as PASS Yes when they reach average or slightly
worse on specific health domains (PF, PI) and relative to “normal”
(ie, GRNF). New to this study is that people with average or
slightly lower SE are more likely to rate themselves as PASS Yes
compared with people with chronic conditions. This alerts pro-
viders to the influence of SE as well as PF and PI to achieve a
positive patient outcome. The corresponding rating relative to
healthy (GRNF) was 7-8 out of 10 or above. Therefore, if thera-
peutically reasonable, clinicians may seek to set goals to achieve
PF, PI, and SE at or slightly worse than average and a GRNF of 7
out 10 or above.
In contrast to a positive patient outcome, a PASS No catego-
rization was associated with worse health domain scores on
PROMIS and GRNF (see table 4). Using the 95% specificity/
sensitivity criteria led to a high PI (>65.0), low PF (<33.8), and
low SE (<41.0) to characterize PASS No status. The 80% speci-
ficity/sensitivity criteria led to less severe scores (see table 4).
Nevertheless, both criteria indicate significant problems with
function (ie, PF), high pain (ie, PI), and low SE as characterizing
PASS No. Similarly, a PASS No threshold for GRNF was 30%-
40% (3-4/10) of normal. Patients meeting these thresholds likely
require treatment or ongoing monitoring targeting a particular
health domain.
The proportions of patients accurately classified suggests the
potential impact of using these thresholds clinically (see table 5
and 6). The 95% specificity/sensitivity criteria was explored to
determine the ability of PRO scales to contribute to more defini-
tive clinical decisions.8 However, the 95% specificity/sensitivity
criteria accuracy (75.0%-79.4%) was similar to the accuracy
(72.3%-75.5%) using the 80% specificity/sensitivity criteria. The
minimal decrease in accuracy using the 80% sensitivity/specificity
thresholds was offset by a much larger proportion of patients
classified (>69.9%), making these thresholds more useful clini-
cally (see table 6). Although higher accuracy is desirable, the
72.3%-75.5% accuracy is impressive given the diversity of the
sample and that PASS status was based solely on a PRO (ie,
PROMIS scales or GRNF). Typically, clinicians might use several
different factors (patient interview and clinical exam) to determine
PASS status.20
This study suggests that providers may gain a better
impression of patient status by including SE and GRNF as well
as PF and PI health domains typically assessed through inter-
view. Whether accuracy for all patients could be improved by
combining scales (ie, multivariate analysis) remains unresolved.
New to this study, the PASS No thresholds provided suggest that
when severity is significant enough patients likely benefit from a
change in treatment or referral. Further studies are necessary to
determine whether patient-derived general health scales like
PROMIS empowers providers to confidently act on pa-
tient needs.
Study limitations
There are several limitations to this study. Although the selected
scales are generic, the sample diagnoses are diverse (see table 2).
Prediction of PASS may vary by diagnosis, which is not addressed
here. Also, multiple health domains, some distinct from the
construct of PASS, may influence a patient’s PASS status. How-
ever, this analysis considered each health domain as a single
predictor of PASS. Multivariate models may find more optimal
combinations of health domains and other factors as important
predictors of PASS.18,20 Although the logistic regression analysis
shows that potentially confounding factors of age, sex, BMI, and
length of follow-up did not influence PRO predictions in this
sample, larger more varied samples are necessary to assess
whether these variables are significant predictors of PASS.18,20
Finally, to validate that the identified thresholds generalize to
other samples, the classification proposed here should be applied
to a separate set of patients.8
Conclusions
This analysis shows that PROMIS and GRNF scales were able to
characterize PASS status with moderate accuracy (w70%) for a
large portion of patients (w70%). New to this study is the asso-
ciation of SE and GRNF with PASS status. PASS was character-
ized as at or slightly worse than the US population average. The
association of the PROMIS and GRNF scales support their use as
possible outcomes to document patient status after primary care
for musculoskeletal problems.
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